Dual inhibition of ERK1/2 and AKT pathways is required to suppress the growth and survival of endometriotic cells and lesions

article OA: closed CC0 ⤵ 13 in-corpus citations
AI-generated summary by claude@2026-06, 2026-06-08

Dual inhibition of ERK1/2 and AKT pathways effectively suppresses the growth and survival of endometriotic cells and lesions.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Butadienes Chromones Endometriosis MAP Kinase Signaling System Morpholines Nitriles Proto-Oncogene Proteins c-akt Animals Butadienes Butadienes Cell Cycle Cell Cycle Cell Line, Tumor Cell Proliferation Cell Proliferation Cell Survival Cell Survival Chromones Chromones Drug Therapy, Combination

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (69)

Cited by (13)

Source provenance

europepmc
last seen: 2026-06-11T06:19:48.454388+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:19:25.021412+00:00
License: CC0 · commercial use OK